CDSCO Panel Approves GSK's Proposal to Double Indian Patient Pool in Dostarlimab Trial Parthika Patel15 July 2025 7:34 PM ISTNew Delhi: In a recent regulatory development, the Subject Expert Committee (SEC) under the Oncology division of the Central Drugs Standard Control...
Do Not Issue Licenses Without New Drug Permission from DCGI, Govt Panel Tells States Farhat Nasim14 July 2025 11:28 PM ISTNew Delhi: In a move to reinforce coordination between central and state drug regulatory bodies, the Drugs Consultative Committee (DCC) has called on...
Pfizer Gets CDSCO Panel Nod To Conduct Phase III Trial of RSV Vaccine in India, Told to Clarify Subject Criteria Dr. Divya Colin13 July 2025 1:00 PM ISTNew Delhi: Pfizer has received approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation...
Unreadable Expiry Dates, Generic Mix-Ups: Govt Panel Proposes Forming Sub-Committee on Medicine Labelling Farhat Nasim12 July 2025 8:25 PM ISTNew Delhi: In a move responding directly to widespread consumer grievances, the Drugs Consultative Committee (DCC), a statutory body under the Central...
SEC Flags Safety, Efficacy Gaps in Troikaa's Rapid IV Paracetamol Bolus Proposal, Seeks More Data Parthika Patel12 July 2025 7:59 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has declined to approve Troikaa...
Cipla Secures CDSCO Panel Nod to Manufacture Amantadine Oral Solution with Trial Waiver Dr. Divya Colin10 July 2025 7:05 PM ISTNew Delhi: Drug major Cipla has received approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
CDSCO Panel Recommends Phase IV Trial for Acne FDC Gel by Precise Biopharma Parthika Patel9 July 2025 11:37 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Dermatology and Allergy division of the Central Drugs Standard Control Organisation (CDSCO)...
CDSCO Panel Asks Dr Reddy's to Submit Indian Data for Triptorelin Pediatric Use Parthika Patel8 July 2025 1:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Endocrinology and Metabolism division of the Central Drugs Standard Control Organisation...
Madras HC Flags Licensing Gap, Says Ayurvedic Imports Must Meet Indian Drug Standards Farhat Nasim7 July 2025 7:42 PM ISTChennai: Observing that "it is necessary for the rule-making authority to modify existing rules, prescribe standards and prepare appropriate forms in...
Expert Panel Approves Post-Marketing Surveillance Study of Eculizumab (Soliris) by AstraZeneca in India Dr. Divya Colin6 July 2025 3:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has granted approval to...
Govt Panel Proposes Braille Cards, Voice-Enabled QR Codes on Medicine Packs to Aid Visually Impaired Farhat Nasim6 July 2025 11:30 AM ISTNew Delhi: In a move aimed at improving accessibility for the visually impaired, the Drugs Consultative Committee (DCC) has recommended placing the...
Pfizer's Abrocitinib Phase III Data Accepted by CDSCO Expert Committee Parthika Patel6 July 2025 10:00 AM ISTNew Delhi: The Subject Expert Committee (SEC) under the Dermatology and Allergy division of the Central Drugs Standard Control Organisation (CDSCO)...
